| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2b4ef3f4468650d208087cfa125416c |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
| filingDate |
2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_437080a11af9f2c80c2dff8ed9675f2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9f5f3216fa3e39728af4c687db9a7cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6297aa1452bdad1eeac812108713a259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2178e165de1a8a4db1341a3553defcb0 |
| publicationDate |
2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2012202855-B2 |
| titleOfInvention |
GLP-1 and exendin related invention |
| abstract |
The invention relates to peptides derived from GLP-1 (Glucagon-like Peptide 1) and exendin-3 and/or exendin-4, which bind to GLP-1 receptors and may be used either marked or unmarked for the production of a means for diagnosis and therapy of benign and pernicious diseases in which GLP-1 receptor expression plays a role. |
| priorityDate |
2004-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |